Tuesdays OTC Watchlist: SUIC, SFIO, SNRG, MRMD, RGBP, ODTC

Following were the most active stock buzzers on Monday. Keep an eye on these stocks this week.

If you are interested in nanocap stocks here is one you should look into

Sino United Worldwide Consolidated Ltd. (OTCMKTS:SUIC) is a great option for crypto and DeFi investors.   SUIC is a venture capital group with interests in AI, IoT, FinTech DeFi and franchise chain stores and factories.

SUIC’s current focus is scaling its DeFi-based supply chain financing solutions.

The global supply chain financial market is large and estimated to reach ~$20 trillion by 2025, according to McKinsey consultants.

In its most recent transaction SUIC has signed a cooperation joint venture agreement with the QQ Pay Pty., Australia to provide cross border payment services to Beneway ecosystem’s customers from the SMEs to the affluent individuals.

SUIC’s deal allow the company to target a much larger customer base in the markets of North America, Europe and the Asia Pacific Region with a combined estimated size of $15 Trillion.

Starfleet Innotech Inc. (OTCMKTS:SFIO) stock was in action in the previous trading session as the stock went down marginally to $0.0460 with over 1.19 million shares traded hands, compared to its average volume of 1.49 million shares.   

Earlier this month, Starfleet Innotech announced that the company is reducing its current authorized share count by 50% from five billion to 2.5 billion. “We believe this reduction leaves enough shares in reserve for us to continue our capital raising efforts, while also minimizing dilution among our shareholders,” said CEO Jeths Lacson.

SusGlobal Energy Corp. (OTCMKTS:SNRG) stock continued to trend higher on Monday. On Monday, the stock moved up 2.42% to $0.53  with more than 81K shares traded hands, compared to its average volume of 366K shares.     

Recently, tThe company announced its financial results for the fourth fiscal quarter and the full fiscal year, both of which ended on December 31, 2021. In addition to that, the company also provided updates with regards to some of the operational progress that it had managed to make. One of the updates was with regards to the purchase of a property spanning 40,535 square feet in Hamilton, Canada. The purchase in question was made by the company through SusGlobal Energy Canada I Ltd, its fully owned subsidiary unit.

However, it was the financial performance that most investors are interested in and it may be a good idea to take a closer look at it. In the fourth quarter of 2021, the company managed to bring in revenues of only $144,246. It proved to be a massive year-on-year drop of as much as 66.63% from the revenues of $432,263 that it had generated in the prior-year quarter.

MariMed Inc. (OTCMKTS:MRMD) stock was in action in the previous trading session as the stock ended flat at $0.7060 with over 358K shares traded hands, compared to its average volume of 592K shares.     

The company announced that the Maryland Medical Cannabis Commission (MMCC) has approved the transfer of 100% of the ownership of Kind Therapeutics U.S.A., LLC (“Kind”), a leading vertically integrated cannabis business to MariMed Inc.

Regen BioPharma Inc. (OTCMKTS:RGBP) stock was in action in the previous trading session as the stock ended down by 0.66% to $0.0069 with over 25.37 million shares traded hands, compared to its average volume of 30.41 million shares.  

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.

Odonate Therapeutics Inc. (OTCMKTS:ODTC) stock was in action in the previous trading session as the stock fell 3% at $1.27 with over 44K shares traded hands, compared to its average volume of 39K shares.   

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.